Mimedx (MDXG) Intangibles (2010 - 2026)
Mimedx's (MDXG) quarterly Intangibles came in at $13.1 million in Q1 2026, up 18.79% year-on-year from $11.1 million in Q1 2025, and down 7.19% quarter-over-quarter from $14.2 million in Q4 2025.
Mimedx (MDXG) Intangibles (2010 - 2026) Analysis & Trends
Mimedx has disclosed Intangibles across 17 years of filings, most recently posting $13.1 million for Q1 2026.
- Intangibles for Q1 2026 came in at $13.1 million, up 18.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.1 million (up 18.79% YoY), and the FY2025 annual result was $14.2 million, up 21.78% from the prior year.
- Intangibles came in at $13.1 million for Q1 2026 at Mimedx, down from $14.2 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $14.2 million in Q4 2025 to a low of $5.0 million in Q3 2022.
- The 5-year median for Intangibles is $11.1 million (2025), against an average of $8.9 million.
- Across the five-year window, Intangibles surged 121.15% in 2024 and retreated 11.86% in 2025, its largest moves.
- Mimedx's Intangibles stood at $5.9 million in 2022, then fell by 10.17% to $5.3 million in 2023, then jumped by 121.15% to $11.6 million in 2024, then increased by 21.78% to $14.2 million in 2025, then retreated by 7.19% to $13.1 million in 2026.
- The last three Intangibles figures came in at $13.1 million (Q1 2026), $14.2 million (Q4 2025), and $11.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 7.73 Mn |
| 10 | Mimedx | 546.28 Mn | 386.51 Mn | 41.62 Mn | 13.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.14 Mn |
| Dec 31, 2025 | 14.16 Mn |
| Sep 30, 2025 | 11.15 Mn |
| Jun 30, 2025 | 12.03 Mn |
| Mar 31, 2025 | 11.06 Mn |
| Dec 31, 2024 | 11.63 Mn |
| Sep 30, 2024 | 11.20 Mn |
| Jun 30, 2024 | 12.05 Mn |
| Mar 31, 2024 | 12.55 Mn |
| Dec 31, 2023 | 5.26 Mn |
| Sep 30, 2023 | 5.40 Mn |
| Jun 30, 2023 | 5.57 Mn |
| Mar 31, 2023 | 5.71 Mn |
| Dec 31, 2022 | 5.85 Mn |
| Sep 30, 2022 | 4.99 Mn |
| Jun 30, 2022 | 5.14 Mn |
| Mar 31, 2022 | 5.27 Mn |
| Dec 31, 2021 | 5.38 Mn |
| Sep 30, 2021 | 5.62 Mn |
| Jun 30, 2021 | 5.75 Mn |